Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
19.06
+0.25 (1.33%)
At close: Mar 9, 2026, 4:00 PM EDT
18.69
-0.37 (-1.94%)
After-hours: Mar 9, 2026, 7:49 PM EDT
Aktis Oncology Market Cap
Aktis Oncology has a market cap or net worth of $1.00 billion as of March 9, 2026.
Market Cap
1.00B
Enterprise Value
766.72M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.06
Market Cap Chart
Since the IPO on January 9, 2026, Aktis Oncology's market cap has increased from $945.40M to $1.00B, an increase of 5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 987.94M | 4.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 1.06B |
| AbCellera Biologics | 1.05B |
| ArriVent BioPharma | 1.04B |
| Inhibrx Biosciences | 1.01B |
| Xeris Biopharma Holdings | 1.00B |
| UroGen Pharma | 996.04M |
| Compass Therapeutics | 992.28M |
| GH Research | 988.13M |